BAX and cholangiocarcinoma: The results, herein, confirm those in our previous study, which showed that soluble factors released from chorion-derived hMSCs inhibited JAK2/STAT3 signaling, reduced Bcl-2 expression, and increased Bax expression in CCA cells [49].